BRIEF published on 05/18/2026 at 07:35, 5 months 14 days ago Fred Chereau nommé Directeur Général de Sensorion Direction Générale Thérapie Génique Sensorion Fred Chereau Pertes D'audition
BRIEF published on 05/18/2026 at 07:35, 5 months 14 days ago Sensorion nomme Fred Chereau au poste de PDG Biotechnologie Thérapie Génique Nomination Du PDG Sensorion Fred Chereau
BRIEF published on 05/18/2026 at 07:35, 5 months 14 days ago Sensorion Appoints Fred Chereau as CEO Biotechnology CEO Appointment Gene Therapy Sensorion Fred Chereau
PRESS RELEASE published on 05/18/2026 at 07:30, 5 months 14 days ago Informations privilégiées / Autres communiqués Sensorion nomme Fred Chereau au poste de Directeur Général, apportant son expertise en biotechnologie et thérapie génique. Amit Munshi continue en tant que Président du Conseil d'Administration Biotechnologie Thérapie Génique Sensorion Amit Munshi Fred Chereau
PRESS RELEASE published on 05/18/2026 at 07:30, 5 months 14 days ago Inside Information / Other news releases Sensorion appoints Fred Chereau as Chief Executive Officer, bringing extensive leadership experience in gene therapy and rare diseases. Amit Munshi continues as Chairman of the Board Gene Therapy Chief Executive Officer Rare Diseases Sensorion Fred Chereau
BRIEF published on 05/13/2026 at 07:35, 5 months 19 days ago Résultats de l'Assemblée Générale de Sensorion Biotechnologie Assemblée Générale Résolutions Adoptées Sensorion Pertes Auditives
BRIEF published on 05/13/2026 at 07:35, 5 months 19 days ago Results of the Sensorion General Meeting Biotechnology General Assembly Resolutions Adopted Hearing Loss Sensory
PRESS RELEASE published on 05/13/2026 at 07:30, 5 months 19 days ago Inside Information / Other news releases Sensorion releases results of Combined General Meeting resolutions. All recommended resolutions adopted with 77.83% capital presence. Details available on website Shareholders General Meeting Resolutions Sensorion Hearing Loss
PRESS RELEASE published on 05/13/2026 at 07:30, 5 months 19 days ago Informations privilégiées / Autres communiqués Sensorion publie les résultats de l’Assemblée générale mixte des actionnaires et annonce l'adoption de toutes les résolutions présentées lors de l'AGM Actionnaires Assemblée Générale Résultats Sensorion Thérapies Innovantes
BRIEF published on 05/05/2026 at 07:35, 5 months 27 days ago Sensorion Participates in ASGCT Annual Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ASGCT 2026
Published on 10/30/2026 at 23:35, 2 days 2 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 2 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 7 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 10 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 15 hours 29 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 21 hours 4 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 9 hours ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 2 days 3 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 2 days 3 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 2 days 3 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
